Finance

Beta
Lists
531335:BOM
Zydus Wellness Ltd
₹572.00
-3.39%
(-20.10) 1D
Jul 22, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531335...
Open
₹586.55
High
₹589.25
Low
₹566.40
Mkt. cap
36.45B
Avg. vol.
74.86K
Volume
19.11K
Dividend
0.21%
Quarterly dividend
₹0.30
Ex-dividend date
Jul 17, 2026
P/E ratio
92.29
52-wk high
₹610.95
52-wk low
₹357.55
EPS
₹6.20
Shares outstanding
39.07M
No. of employees
2K
Open
₹586.55
High
₹589.25
Low
₹566.40
Mkt. cap
36.45B
Avg. vol.
74.86K
Volume
19.11K
Dividend
0.21%
Quarterly dividend
₹0.30
Ex-dividend date
Jul 17, 2026
P/E ratio
92.29
52-wk high
₹610.95
52-wk low
₹357.55
EPS
₹6.20
Shares outstanding
39.07M
No. of employees
2K
News stories
From sources across the web
Profile
Zydus Wellness is an Indian consumer goods company, which produces nutrition and skincare products. Headquartered in Ahmedabad, it is a subsidiary of the pharmaceutical company Zydus Lifesciences. Its brands include Glucon-D, Sugar Free, EverYuth, Complan, and Nycil. As of 2021, the company operates three manufacturing plants, one in Gujarat and two in Sikkim. Wikipedia
About Zydus Wellness Ltd
CEOTarun G. Arora
Employees1.68K
Founded1994
Headquarters-
SectorFood
Websitezyduswellness.com
Next call in 13 days
Tue, Aug 4, 5:30 AM
Fiscal period
Q1 2027
EPS / Est. (INR)
- / ₹3.93
Revenue / Est. (INR)
- / 14.66B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.61B
6.50B
9.65B
14.85B
Cost of goods sold
3.88B
3.06B
3.53B
5.43B
Cost of revenue
3.88B
3.06B
3.53B
5.43B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.01B
1.60B
2.53B
4.47B
Operating expense
3.29B
3.48B
6.07B
7.32B
Total operating expenses
7.16B
6.54B
9.60B
12.75B
Operating income
1.44B
-37.00M
48.00M
2.10B
Other non operating income
30.00M
14.00M
8.00M
-71.00M
EBT including unusual items
1.45B
-506.00M
-415.00M
1.77B
EBT excluding unusual items
1.45B
-164.00M
-349.00M
1.74B
Income tax expense
174.00M
22.00M
-16.00M
153.00M
Effective tax rate
11.98%
-4.35%
3.86%
8.63%
Other operating expenses
1.17B
1.63B
2.99B
2.29B
Net income
1.28B
-528.00M
-399.00M
1.62B
Net profit margin
14.86%
-8.12%
-4.14%
10.91%
Earnings per share
4.02
-0.58
-1.06
5.09
Interest and investment income
-
-
-
14.00M
Interest expense
-25.00M
-157.00M
-412.00M
-356.00M
Net interest expenses
-25.00M
-157.00M
-412.00M
-342.00M
Depreciation and amortization charges
108.00M
251.00M
555.00M
553.00M
EBITDA
1.51B
142.50M
112.50M
2.46B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer